A detailed history of Gf Fund Management Co. Ltd. transactions in Moderna, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 10,386 shares of MRNA stock, worth $296,416. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,386
Previous 8,951 16.03%
Holding current value
$296,416
Previous $372 Million 20.89%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 28, 2025

BUY
$28.35 - $47.53 $40,682 - $68,205
1,435 Added 16.03%
10,386 $294 Million
Q4 2024

Feb 18, 2025

BUY
$36.85 - $63.93 $329,844 - $572,237
8,951 New
8,951 $372 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $11.2B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Gf Fund Management Co. Ltd. Portfolio

Follow Gf Fund Management Co. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gf Fund Management Co. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Gf Fund Management Co. Ltd. with notifications on news.